Drugs / 1α-D3
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02993302 Comparator | Jul 2014 → Mar 2015 | Graves disease | Dr Cipto Mangunkusumo General Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 1α-D3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02993302 ↗ |
| Route | Oral | “given oral 1α-D3” NCT02993302 ↗ |